Related Experiment Video
Updated: Apr 5, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
1Cellular and Molecular Signaling, Newark, New Jersey 07101, USA. wntin75@yahoo.com.
Abstract:
Mammalian forkhead transcription factors of the O class (FoxO) are exciting targets under consideration for the development of new clinical entities to treat metabolic disorders and diabetes mellitus (DM). DM, a disorder that currently affects greater than 350 million individuals globally, can become a devastating disease that leads to cellular injury through oxidative stress pathways and affects multiple systems of the body. FoxO proteins can regulate insulin signaling, gluconeogenesis, insulin resistance, immune cell migration, and cell senescence. FoxO proteins also control cell fate through oxidative stress and pathways of autophagy and apoptosis that either lead to tissue regeneration or cell demise. Furthermore, FoxO signaling can be dependent upon signal transduction pathways that include silent mating type information regulation 2 homolog 1 (S. cerevisiae) (SIRT1), Wnt, and Wnt1 inducible signaling pathway protein 1 (WISP1). Cellular metabolic pathways driven by FoxO proteins are complex, can lead to variable clinical outcomes, and require in-depth analysis of the epigenetic and post-translation protein modifications that drive FoxO protein activation and degradation.
Insights
Forkhead box O (FoxO) transcription factors are key regulators of cellular metabolism and stress responses, offering potential therapeutic targets for diabetes mellitus (DM). Understanding FoxO signaling pathways is crucial for developing new treatments for this widespread metabolic disorder.
Area of Science:
- Molecular Biology
- Cellular Metabolism
- Endocrinology
Background:
- Mammalian forkhead transcription factors of the O class (FoxO) are implicated in metabolic regulation.
- Diabetes mellitus (DM) affects over 350 million people globally and involves cellular injury via oxidative stress.
- FoxO proteins influence critical pathways including insulin signaling, gluconeogenesis, and cell fate.
Purpose of the Study:
- To explore the role of FoxO transcription factors as potential therapeutic targets for metabolic disorders, particularly diabetes mellitus.
- To elucidate the complex regulatory mechanisms governing FoxO protein activity.
Main Methods:
- Analysis of FoxO protein involvement in insulin signaling, gluconeogenesis, and oxidative stress pathways.
- Investigation of FoxO-dependent regulation of autophagy, apoptosis, and cell senescence.
- Examination of signaling pathways influencing FoxO, including SIRT1, Wnt, and WISP1.
Main Results:
- FoxO proteins regulate key metabolic processes and cellular responses to stress.
- FoxO signaling is interconnected with pathways controlling cell survival and death.
- Epigenetic and post-translational modifications significantly impact FoxO protein activity.
Conclusions:
- FoxO transcription factors represent promising targets for novel therapeutic strategies against metabolic disorders like DM.
- Further research into the complex regulation of FoxO signaling is essential for clinical applications.
- Understanding FoxO-driven metabolic pathways can lead to improved treatments for diabetes and related conditions.
Related Concept Videos
Master Transcription Regulators
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Tissue Renewal without Stem Cells
However, failure of such a system...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Regulation of Angiogenesis and Blood Supply
Insulin: The Receptor and Signaling Pathways

